Beam Therapeutics Inc at Bank of America Biotech SMID Cap Conference Transcript
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the ask questions tab on the webcast page.
At this time, it is my pleasure to turn the program over to your host, Greg Harrison.
Hi, and welcome to the Bank of America SMID Biotech Virtual Conference. I'm Greg Harrison, one of the biotech analyst here at BofA. And today, I'm happy to introduce Beam Therapeutics, represented by John Evans, CEO; and Giuseppe Ciaramella, President and Chief Scientific Officer. Thanks for joining us, everyone. And for those of you out there watching, if you want to send any questions, I'm happy to ask them on your behalf.
John, if you'd like to start off with some opening remarks, that would be great, and then we can jump into Q&A.
Sounds good. It's great to be here, Greg, and thanks for having us. So Beam, as people may be familiar
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |